Ntagi approves serum institute of india covovax covid vaccine for 12 to 17 age group skf mgb Pi News

New Delhi: The Permanent Technical Subcommittee on Immunization of the National Technical Advisory Group (NTAGI) has recommended the inclusion of Kovovax in immunizations for the 12-17 age group. The vaccine is manufactured by the Serum Institute of India, Pune. The Drug Controller General of India (DCGI) approved emergency use of the vaccine on December 28 last year for adults and on March 9 this year for the 12-17 age group.

Vaccination will help
Official sources said Entagi’s working group had already approved Covovax after reviewing the data. The Standing Technical Sub-Committee met on Friday and stated that the vaccine could be used to vaccinate people between the ages of 12 and 17.

Also read:
4th COVID-19 Wave: The chances of a fourth wave of Coronado are very low, taking the form of a local disease.

The government is not buying the vaccine yet
Prakash Kumar Singh, director of government and regulatory affairs at SII, had written a letter to the Union Ministry of Health requesting that children and adults over 12 years of age be included in the vaccination. The company is providing the vaccine to private hospitals at a rate of Rs 900 per dose, for which GST is separate. The central government is not yet buying the vaccine.

Also read:
M Modi warns in meeting with CM, Corona threat not imminent, be alert

Poonawala has made this appeal

In an exclusive interview with news agency ANI earlier this month, Adar Poonawala, CEO of the Serum Institute of India (SII), said Kovax would be used for children. It has been approved by the country’s drug regulator DCGI. We are waiting for the Government of India to allow it to be installed. You need to put it on the CoWIN app to make it available to everyone.

Published by:Shaik Khaleel Farhaad

First published:

First read News18 Urdu on Urdu News, Breaking News in Urdu. Today’s latest news, live news update, read the most trusted Urdu news, on News18Urdu.com, know all the details related to your state, country and abroad and especially the Middle East, entertainment, sports, business, health, education and employment. Follow News18 Urdu on Twitter, Facebook, Instagram, YouTube, Daily Hunt, Share Chat and Quip.